- en: A Machine Learning Approach to Predicting MGMT Methylation Status in Glioblastoma
    Patients
  id: totrans-0
  prefs:
  - PREF_H1
  type: TYPE_NORMAL
  zh: 一种机器学习方法预测胶质母细胞瘤患者的MGMT甲基化状态
- en: 原文：[https://towardsdatascience.com/a-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339?source=collection_archive---------12-----------------------#2023-07-26](https://towardsdatascience.com/a-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339?source=collection_archive---------12-----------------------#2023-07-26)
  id: totrans-1
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 原文：[https://towardsdatascience.com/a-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339?source=collection_archive---------12-----------------------#2023-07-26](https://towardsdatascience.com/a-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339?source=collection_archive---------12-----------------------#2023-07-26)
- en: Radiomics in Oncology
  id: totrans-2
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 肿瘤学中的放射组学
- en: '[](https://medium.com/@jevans2532?source=post_page-----b996e36cc339--------------------------------)[![Jarrett
    Evans](../Images/74a9607261cc5ad1078549ee660b52cd.png)](https://medium.com/@jevans2532?source=post_page-----b996e36cc339--------------------------------)[](https://towardsdatascience.com/?source=post_page-----b996e36cc339--------------------------------)[![Towards
    Data Science](../Images/a6ff2676ffcc0c7aad8aaf1d79379785.png)](https://towardsdatascience.com/?source=post_page-----b996e36cc339--------------------------------)
    [Jarrett Evans](https://medium.com/@jevans2532?source=post_page-----b996e36cc339--------------------------------)'
  id: totrans-3
  prefs: []
  type: TYPE_NORMAL
  zh: '[](https://medium.com/@jevans2532?source=post_page-----b996e36cc339--------------------------------)[![贾雷特·埃文斯](../Images/74a9607261cc5ad1078549ee660b52cd.png)](https://medium.com/@jevans2532?source=post_page-----b996e36cc339--------------------------------)[](https://towardsdatascience.com/?source=post_page-----b996e36cc339--------------------------------)[![数据科学前沿](../Images/a6ff2676ffcc0c7aad8aaf1d79379785.png)](https://towardsdatascience.com/?source=post_page-----b996e36cc339--------------------------------)
    [贾雷特·埃文斯](https://medium.com/@jevans2532?source=post_page-----b996e36cc339--------------------------------)'
- en: ·
  id: totrans-4
  prefs: []
  type: TYPE_NORMAL
  zh: ·
- en: '[Follow](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fsubscribe%2Fuser%2F9612ed1f387a&operation=register&redirect=https%3A%2F%2Ftowardsdatascience.com%2Fa-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339&user=Jarrett+Evans&userId=9612ed1f387a&source=post_page-9612ed1f387a----b996e36cc339---------------------post_header-----------)
    Published in [Towards Data Science](https://towardsdatascience.com/?source=post_page-----b996e36cc339--------------------------------)
    ·5 min read·Jul 26, 2023[](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fvote%2Ftowards-data-science%2Fb996e36cc339&operation=register&redirect=https%3A%2F%2Ftowardsdatascience.com%2Fa-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339&user=Jarrett+Evans&userId=9612ed1f387a&source=-----b996e36cc339---------------------clap_footer-----------)'
  id: totrans-5
  prefs: []
  type: TYPE_NORMAL
  zh: '[关注](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fsubscribe%2Fuser%2F9612ed1f387a&operation=register&redirect=https%3A%2F%2Ftowardsdatascience.com%2Fa-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339&user=Jarrett+Evans&userId=9612ed1f387a&source=post_page-9612ed1f387a----b996e36cc339---------------------post_header-----------)
    发表在 [Towards Data Science](https://towardsdatascience.com/?source=post_page-----b996e36cc339--------------------------------)
    · 5 分钟阅读 · 2023年7月26日[](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fvote%2Ftowards-data-science%2Fb996e36cc339&operation=register&redirect=https%3A%2F%2Ftowardsdatascience.com%2Fa-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339&user=Jarrett+Evans&userId=9612ed1f387a&source=-----b996e36cc339---------------------clap_footer-----------)'
- en: --
  id: totrans-6
  prefs: []
  type: TYPE_NORMAL
  zh: --
- en: '[](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fbookmark%2Fp%2Fb996e36cc339&operation=register&redirect=https%3A%2F%2Ftowardsdatascience.com%2Fa-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339&source=-----b996e36cc339---------------------bookmark_footer-----------)![](../Images/b0c66015662469f6c7b7f58d2eaddb97.png)'
  id: totrans-7
  prefs: []
  type: TYPE_NORMAL
  zh: '[](https://medium.com/m/signin?actionUrl=https%3A%2F%2Fmedium.com%2F_%2Fbookmark%2Fp%2Fb996e36cc339&operation=register&redirect=https%3A%2F%2Ftowardsdatascience.com%2Fa-machine-learning-approach-to-predicting-mgmt-methylation-status-in-glioblastoma-patients-b996e36cc339&source=-----b996e36cc339---------------------bookmark_footer-----------)![](../Images/b0c66015662469f6c7b7f58d2eaddb97.png)'
- en: Photo by [National Cancer Institute](https://unsplash.com/@nci?utm_source=medium&utm_medium=referral)
    on [Unsplash](https://unsplash.com/?utm_source=medium&utm_medium=referral)
  id: totrans-8
  prefs: []
  type: TYPE_NORMAL
  zh: 照片由 [国家癌症研究所](https://unsplash.com/@nci?utm_source=medium&utm_medium=referral)
    提供，发布在 [Unsplash](https://unsplash.com/?utm_source=medium&utm_medium=referral)
- en: Introduction
  id: totrans-9
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 介绍
- en: 'Today, we’re going to explore a study done for glioblastoma patients that was
    published in the journal Nature, Scientific Reports: [*Improving MGMT methylation
    status prediction of glioblastoma through optimizing radiomics features using
    genetic algorithm-based machine learning approach*](https://www.nature.com/articles/s41598-022-17707-w).
    The goal of this study was to try to predict O6-Methylguanine-DNA-methyltransferae
    (MGMT) methylation status. The reason why it is important to be able to predict
    this status is because it can be a good indicator of how effective the chemotherapy
    treatment Temozolomide (TMZ) will be.'
  id: totrans-10
  prefs: []
  type: TYPE_NORMAL
  zh: 今天，我们将探讨一项针对胶质母细胞瘤患者的研究，该研究发表在《自然》杂志的Scientific Reports上：[*通过优化放射组学特征使用基于遗传算法的机器学习方法改善胶质母细胞瘤MGMT甲基化状态预测*](https://www.nature.com/articles/s41598-022-17707-w)。该研究的目标是尝试预测O6-甲基鸟嘌呤-DNA-甲基转移酶（MGMT）甲基化状态。能够预测这一状态的重要原因在于，它可以很好地指示化疗药物替莫唑胺（TMZ）的效果。
- en: '**Temozolomide Overview**'
  id: totrans-11
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: '**替莫唑胺概述**'
- en: ''
  id: totrans-12
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: TMZ is an alkylating agent that works by damaging the DNA in cancer cells, which
    ultimately leads to cell death. TMZ also makes the cells more sensitive to radiation.
    This is a big factor in cancer treatment as radiation is used to help kill cancer
    cells.
  id: totrans-13
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: TMZ是一种烷化剂，通过损伤癌细胞中的DNA来发挥作用，最终导致细胞死亡。TMZ还使细胞对放射线更敏感。这在癌症治疗中是一个重要因素，因为放射线用于帮助杀死癌细胞。
- en: This study sets out to try to find a new way to predict the MGMT methylation
    status through machine learning. If successful, this can help alleviate some of
    the technical limitations and invasive procedures that are currently in place
    to obtain the tumor specimens needed to test for the status.
  id: totrans-14
  prefs: []
  type: TYPE_NORMAL
  zh: 这项研究旨在通过机器学习寻找预测MGMT甲基化状态的新方法。如果成功，这可以帮助缓解目前为获取肿瘤标本而需进行的技术限制和侵入性程序。
- en: It is important that glioblastoma (GBM) cancers are dealt with efficiently and
    effectively due to the deadliness they pose to the patients who develop them.
    With a median survival of 14–16 months, they account for about 45% of all malignant
    central nervous system tumors.
  id: totrans-15
  prefs: []
  type: TYPE_NORMAL
  zh: 由于胶质母细胞瘤（GBM）对患者的致命威胁，处理这种癌症的效率和有效性非常重要。其中位生存期为14至16个月，占所有恶性中枢神经系统肿瘤的约45%。
- en: Methods
  id: totrans-16
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 方法
- en: This team looked to leverage a two-stage approach to predict the appropriate
    MGMT methylation status. First by eliminating noisy radiomics features and next
    by implementing classification algorithms into a genetic algorithm to help identify
    the best prediction features.
  id: totrans-17
  prefs: []
  type: TYPE_NORMAL
  zh: 该团队寻求利用两阶段方法来预测适当的MGMT甲基化状态。首先是通过消除噪声放射组学特征，然后将分类算法实施到遗传算法中，以帮助识别最佳预测特征。
- en: There were various machine-learning techniques that were tested during this
    research. The purpose was to find the most meaningful radiomics features for prediction.
    They did this by extracting radiomics features from multimodal images from magnetic
    resonance images (MRI). The two-stage feature selection method started with an
    eXtreme Gradient Boosting (XGBoost) model followed by a genetic algorithm (GA)-based
    wrapper model. GA models work in a similar fashion to natural selection, where
    the ‘fittest’ set of features for predictions are identified.
  id: totrans-18
  prefs: []
  type: TYPE_NORMAL
  zh: 在这项研究中测试了各种机器学习技术。目的是寻找对预测最有意义的放射组学特征。他们通过从磁共振成像（MRI）的多模态图像中提取放射组学特征来实现这一目标。两阶段特征选择方法从eXtreme
    Gradient Boosting（XGBoost）模型开始，随后使用基于遗传算法（GA）的包装模型。GA模型的工作方式类似于自然选择，通过识别“最适合”的特征集进行预测。
- en: The data that was used were preprocessed and segmented multimodal MRI features
    from The Cancer Genome Atlas. In total, there were 53 GBM patients that were included
    and 704 radiomics features were obtained.
  id: totrans-19
  prefs: []
  type: TYPE_NORMAL
  zh: 使用的数据是来自癌症基因组图谱的预处理和分割的多模态MRI特征。总共包括了53名GBM患者，并获得了704个放射组学特征。
- en: 'The workflow stage of the genetic algorithm consisted of six different steps:
    generation of the initial population, fitness assessment, selection of parents,
    crossover, mutation, and population replacement for the next generation. The formula
    that was used for selection probability (where the features are selected based
    on their performance in the fitness assessment stage) is shown below:'
  id: totrans-20
  prefs: []
  type: TYPE_NORMAL
  zh: 遗传算法的工作流程阶段包括六个不同的步骤：初始种群的生成、适应度评估、父母选择、交叉、突变和下一代的种群替换。用于选择概率的公式（其中特征是根据其在适应度评估阶段的表现进行选择）如下所示：
- en: '![](../Images/ddf186a207ca894c6d2cd516cd872f2a.png)'
  id: totrans-21
  prefs: []
  type: TYPE_IMG
  zh: '![](../Images/ddf186a207ca894c6d2cd516cd872f2a.png)'
- en: Selection Probability Formula
  id: totrans-22
  prefs: []
  type: TYPE_NORMAL
  zh: 选择概率公式
- en: Once the initial features were extracted from the XGBoost algorithm it was time
    to do classification using the features to predict which patients fell into the
    classes on MGMT Methylated and Unmethylated and used that as the fitness assessment.
    They tried implementing three different machine learning algorithms into the fitness
    assessment piece of the genetic algorithm workflow. They used Random Forest (RF),
    XGBoost, and Support Vector Machines (SVM). To implement the algorithms, they
    utilized the Python machine learning library SKlearn.
  id: totrans-23
  prefs: []
  type: TYPE_NORMAL
  zh: 一旦从 XGBoost 算法中提取了初始特征，就该使用这些特征进行分类，以预测哪些患者属于 MGMT 甲基化和非甲基化类别，并将其作为适应度评估。他们尝试将三种不同的机器学习算法应用于遗传算法工作流中的适应度评估部分。他们使用了随机森林（RF）、XGBoost
    和支持向量机（SVM）。为了实现这些算法，他们利用了 Python 机器学习库 SKlearn。
- en: Results
  id: totrans-24
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 结果
- en: 'Once they trained the three different versions of algorithms, they assessed
    model performance with three different measurements: accuracy, specificity, and
    recall. To compare the performance, they used the mean of running cross-validation
    20 times and used a Kolmogorov-Smirnov test for evaluation.'
  id: totrans-25
  prefs: []
  type: TYPE_NORMAL
  zh: 一旦训练了三种不同版本的算法，他们使用三种不同的测量标准来评估模型性能：准确率、特异性和召回率。为了比较性能，他们使用了运行 20 次交叉验证的平均值，并使用了
    Kolmogorov-Smirnov 检验进行评估。
- en: The best result was achieved by the Random Forest algorithm incorporated into
    the Genetic Algorithm (GA-RF). This technique outperformed the others in all of
    the evaluation metrics with an accuracy of 0.925, a sensitivity of 0.894, and
    a specificity of 0.966.
  id: totrans-26
  prefs: []
  type: TYPE_NORMAL
  zh: 最佳结果是通过将随机森林算法融入遗传算法（GA-RF）实现的。该技术在所有评估指标中都优于其他方法，准确率为 0.925，灵敏度为 0.894，特异性为
    0.966。
- en: After the GA-RF model finished there was an optimal subset of 22 radiomics features.
    Amongst these features included 17 textural features, 3 histogram-based features,
    1 volume feature, and 1 intensity feature. Textural features can play a helping
    role for clinicians by reflecting spatial intensity correlations and distributions
    of voxels that could help quantify the “multiregional variations” in blood flow,
    edema, and necrosis. Histogram features can be used to illustrate the frequency
    distribution of intensity values that occur in an image.
  id: totrans-27
  prefs: []
  type: TYPE_NORMAL
  zh: 在 GA-RF 模型完成后，得到了一个最佳的 22 个放射组学特征的子集。这些特征中包括 17 个纹理特征、3 个基于直方图的特征、1 个体积特征和 1
    个强度特征。纹理特征可以通过反映空间强度相关性和体素的分布，帮助临床医生定量评估血流、浮肿和坏死的“多区域变化”。直方图特征可以用来说明图像中强度值的频率分布。
- en: Expanded Use-Case
  id: totrans-28
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 扩展的使用案例
- en: To test the more widespread applicability of the model the team used the learned
    features on a new dataset. The dataset they used this time was for patients with
    Low-Grade Gliomas (LGG). They applied the learned features directly and didn’t
    do any additional feature selections.
  id: totrans-29
  prefs: []
  type: TYPE_NORMAL
  zh: 为了测试模型的更广泛适用性，团队使用了在新数据集上学到的特征。他们这次使用的数据集是低级别胶质瘤（LGG）患者的数据集。他们直接应用了学到的特征，没有进行任何额外的特征选择。
- en: The results for the GA-RF model on the LGG dataset were an accuracy of 0.75,
    a sensitivity of 0.78, and a specificity of 0.62\. Without any transfer learning
    or fine-tuning done, these are promising results.
  id: totrans-30
  prefs: []
  type: TYPE_NORMAL
  zh: GA-RF 模型在 LGG 数据集上的结果为准确率 0.75，灵敏度 0.78，特异性 0.62。没有进行任何迁移学习或微调，这些结果还是相当有前景的。
- en: By receiving strong performance with the features applied to the LGG dataset
    the researchers were able to show that these features could potentially be reused
    for other similar diseases.
  id: totrans-31
  prefs: []
  type: TYPE_NORMAL
  zh: 通过在 LGG 数据集上应用这些特征取得强劲表现，研究人员能够展示这些特征有可能被重用于其他类似疾病。
- en: Limitations
  id: totrans-32
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 限制
- en: A potential limitation of this technique is that with a small number of patients,
    researchers may experience a high-dimensionality-related problem. This occurs
    when the number of features is high compared to the amount of training data that
    is available. If this happens it can be challenging to learn accurate relationships
    between the data and the target variable.
  id: totrans-33
  prefs: []
  type: TYPE_NORMAL
  zh: 该技术的一个潜在限制是，当患者数量较少时，研究人员可能会遇到高维度相关的问题。这种情况发生在特征数量相对于可用训练数据量较高时。如果发生这种情况，学习数据和目标变量之间的准确关系可能会很具挑战性。
- en: High-dimensionality problems are a widespread issue within the space of radiomics,
    not just in this study. To overcome this limitation the team used cross-validation
    to be more certain of the results they were receiving.
  id: totrans-34
  prefs: []
  type: TYPE_NORMAL
  zh: 高维度问题在放射组学领域普遍存在，而不仅仅是本研究中的问题。为了克服这一限制，团队使用了交叉验证，以更确定他们得到的结果。
- en: '**Cross-validation Overview**'
  id: totrans-35
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: '**交叉验证概述**'
- en: ''
  id: totrans-36
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: Cross-validation works by splitting the data that are used for training and
    testing into different groups for each iteration of the validation. By doing this
    multiple times and taking the mean of the results you have more confidence that
    your model can repeatedly obtain the results it is giving.
  id: totrans-37
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 交叉验证通过将用于训练和测试的数据分成不同的组来进行每次验证的迭代。通过多次这样做并取结果的平均值，你可以更有信心地认为你的模型能够重复地获得它给出的结果。
- en: In cancer treatment, clinicians are reliant upon tumor characteristics and grades
    so that they can optimize treatment for chemotherapy, radiation therapy, and surgery.
  id: totrans-38
  prefs: []
  type: TYPE_NORMAL
  zh: 在癌症治疗中，临床医生依赖于肿瘤的特征和等级，以便优化化疗、放疗和手术治疗。
- en: Conclusion
  id: totrans-39
  prefs:
  - PREF_H2
  type: TYPE_NORMAL
  zh: 结论
- en: If this technique continues to be developed and eventually utilized, it could
    be a way for doctors to noninvasively understand the MGMT methylation status of
    their patients. This information can help them to make a more informed treatment
    decision that could help lead to better prognoses within patients. This also opens
    the door for other potential ways radiomics can be utilized in Oncology.
  id: totrans-40
  prefs: []
  type: TYPE_NORMAL
  zh: 如果这一技术继续得到发展并最终被利用，它可能成为医生非侵入性了解患者MGMT甲基化状态的一种方式。这些信息可以帮助他们做出更明智的治疗决策，从而有助于改善患者的预后。这也为放射组学在肿瘤学中可能的其他应用打开了大门。
- en: Do, D.T., Yang, MR., Lam, L.H.T. *et al.* Improving MGMT methylation status
    prediction of glioblastoma through optimizing radiomics features using genetic
    algorithm-based machine learning approach. *Sci Rep* **12**, 13412 (2022). [https://doi.org/10.1038/s41598-022-17707-w](https://doi.org/10.1038/s41598-022-17707-w)
  id: totrans-41
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: Do, D.T., Yang, MR., Lam, L.H.T. *等*。通过优化放射组学特征来改善胶质母细胞瘤MGMT甲基化状态预测，使用基于遗传算法的机器学习方法。
    *Sci Rep* **12**, 13412 (2022)。 [https://doi.org/10.1038/s41598-022-17707-w](https://doi.org/10.1038/s41598-022-17707-w)
- en: ''
  id: totrans-42
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: Eberhart, Karin, Ozlem Oral, and Devrim Gozuacik. “Chapter 13 — Induction of
    Autophagic Cell Death by Anticancer Agents.” *ScienceDirect*, 2014, [https://www.sciencedirect.com/topics/neuroscience/temozolomide#:~:text=Temozolomide%20(TMZ)%20is%20a%20small,damage%20and%20tumor%20cell%20death](https://www.sciencedirect.com/topics/neuroscience/temozolomide#:~:text=Temozolomide%20(TMZ)%20is%20a%20small,damage%20and%20tumor%20cell%20death).
    Accessed 12 July 2023.
  id: totrans-43
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: Eberhart, Karin, Ozlem Oral, 和 Devrim Gozuacik。“第13章 — 通过抗癌药物诱导自噬性细胞死亡。” *ScienceDirect*，2014年，[https://www.sciencedirect.com/topics/neuroscience/temozolomide#:~:text=Temozolomide%20(TMZ)%20is%20a%20small,damage%20and%20tumor%20cell%20death](https://www.sciencedirect.com/topics/neuroscience/temozolomide#:~:text=Temozolomide%20(TMZ)%20is%20a%20small,damage%20and%20tumor%20cell%20death)。访问日期：2023年7月12日。
- en: ''
  id: totrans-44
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: National Cancer Institute. ‘Trials Produce Practice-Changing Results for Brain
    Cancer.’ *Cancer Currents Blog*, 9 June 2016, [https://www.cancer.gov/news-events/cancer-currents-blog/2016/asco-temozolomide-brain](https://www.cancer.gov/news-events/cancer-currents-blog/2016/asco-temozolomide-brain).
    Accessed 18 July 2023.
  id: totrans-45
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 国家癌症研究所。‘试验产生了对脑癌治疗有影响的结果。’ *癌症动态博客*，2016年6月9日，[https://www.cancer.gov/news-events/cancer-currents-blog/2016/asco-temozolomide-brain](https://www.cancer.gov/news-events/cancer-currents-blog/2016/asco-temozolomide-brain)。访问日期：2023年7月18日。
- en: ''
  id: totrans-46
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: American Cancer Society. “How Chemotherapy Drugs Work.” American Cancer Society,
    22 Nov. 2019, [https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html](https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html).
    Accessed 25 July 2023.
  id: totrans-47
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 美国癌症学会。“化疗药物的作用机制。” 美国癌症学会，2019年11月22日，[https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html](https://www.cancer.org/treatment/treatments-and-side-effects/treatment-types/chemotherapy/how-chemotherapy-drugs-work.html)。访问日期：2023年7月25日。
- en: ''
  id: totrans-48
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: 'European Society for Medical Oncology. “MGMT Promoter Methylation in Glioma:
    ESMO Biomarker Factsheet.” Oncology Pro, [updated 2019 Jan 18], [https://oncologypro.esmo.org/education-library/factsheets-on-biomarkers/mgmt-promoter-methylation-in-glioma](https://oncologypro.esmo.org/education-library/factsheets-on-biomarkers/mgmt-promoter-methylation-in-glioma).
    Accessed 9 July 2023.'
  id: totrans-49
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 欧洲医学肿瘤学会。“胶质瘤中的MGMT启动子甲基化：ESMO生物标志物简报。” Oncology Pro，[更新于2019年1月18日]，[https://oncologypro.esmo.org/education-library/factsheets-on-biomarkers/mgmt-promoter-methylation-in-glioma](https://oncologypro.esmo.org/education-library/factsheets-on-biomarkers/mgmt-promoter-methylation-in-glioma)。访问日期：2023年7月9日。
- en: ''
  id: totrans-50
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
- en: 'Creative Commons license link: [https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)'
  id: totrans-51
  prefs:
  - PREF_BQ
  type: TYPE_NORMAL
  zh: 创作共用许可证链接：[https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)
